Clinical Services

ISOTRETINOIN (ROACCUTANE)

ISOTRETINOIN (ROACCUTANE)

ACCEPT:

  • For 4 weeks after completion of therapy

DEFER:

  • For 4 weeks from the last dose

ADDITIONAL INFORMATION

Isotretinoin (Roaccutane) when taken systemically can cause birth defects in babies if they exposed to them in the womb and it is therefore important to allow time for the drug to be cleared from the blood of a donor

 

IBTS/MEDD/DSGDE/0001Attachment 4.274Ver 1.1
Sign up to Our Newsletter

Sign up to Our Newsletter

loading form...